Q Biomed Inc (QBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2021 | 08-2021 | 05-2021 | 02-2021 | 11-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 344 | 151 | 290 | 435 | 177 |
| Receivables | 80 | 39 | 41 | N/A | N/A |
| Inventories | 22 | N/A | N/A | N/A | N/A |
| TOTAL | $460 | $239 | $410 | $475 | $224 |
| Non-Current Assets | |||||
| Intangibles | 350 | 363 | 375 | 388 | 400 |
| TOTAL | $350 | $363 | $375 | $388 | $400 |
| Total Assets | $810 | $602 | $785 | $862 | $624 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,053 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,345 | 1,374 | 1,021 | 870 | 722 |
| Accrued Expenses | 1,097 | 1,034 | 957 | 890 | 885 |
| TOTAL | $5,495 | $3,598 | $2,977 | $2,649 | $1,699 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,495 | $3,598 | $2,977 | $2,649 | $1,699 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,603 | 28,599 | 27,587 | 26,122 | 25,859 |
| Common Shares | 29 | 28 | 28 | 26 | 24 |
| Retained earnings | -64,127 | -62,057 | -60,269 | -58,361 | -55,886 |
| Other shareholders' equity | 6,077 | 6,077 | 6,077 | 6,089 | 7,130 |
| TOTAL | $-4,685 | $-2,997 | $-2,192 | $-1,786 | $-1,076 |
| Total Liabilities And Equity | $809 | $602 | $785 | $862 | $624 |